Back to Search
ZIA DEHQANZADA, M.D.
M.D.
Surgery Physician
NPI: 1003015652IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
0101233249(VA)
Education
UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)
Class of 2001
Research & Publications (6)
Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
PMID 18245541·Clin Cancer Res·2008
3-trial
Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology.
PMID 17273752·Oncol Rep·2007
3-trial
Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine.
PMID 16783576·Cancer Immunol Immunother·2007
3-trial
Pattern of serum immunoreactivity against breast cancer cell lysates may predict severity of disease in breast cancer patients.
PMID 17440722·Cancer Immunol Immunother·2007
8-other
Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patients.
PMID 16428490·Clin Cancer Res·2006
8-other
Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients.
PMID 16243821·Clin Cancer Res·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- CMR 442, BOX 291
APO, AE 09042 - Phone
- 496221173440
Quick Facts
- NPI
- 1003015652
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 25
- Publications
- 6
Are you this provider?
Claim Your Profile